Enrollment is open — Try it free for 7 days. No obligation, no cohorts, no waiting. See Enrollment Options →
PMHNP Confidence

Saying No to Controlled Substances: A New PMHNP Confidence Script

A new PMHNP confidence script for declining inappropriate controlled substance requests — with exact language, rationale, and de-escalation frameworks.

Abstract illustration of a locked prescription pad and brass scales representing PMHNP clinical restraint



Audio Overview

Listen to an in-depth podcast of this post

Two hosts break down this PMHNP guide on controlled substance refusals — no reading required.

TL;DR — Controlled Substance Refusals

New PMHNPs face pressure, manipulation, and even bullying around controlled substance refusals — situations where they end up writing prescriptions they would not otherwise consider. Confidence is not about having a perfect answer — it is about having a rehearsed one.

This post delivers a five-step framework for controlled substance refusals. In addition, you will get exact patient-facing language, documentation pearls, and the mental reframe that stops most clinicians from caving under pressure.

Roughly one in four new graduate PMHNPs reports feeling pressured to prescribe a controlled substance they believed was inappropriate. Notably, this happens within the first ninety days of practice. That pressure does not mean the clinician is weak. It means the encounter was engineered — intentionally or otherwise — to make “yes” feel easier than “no.”

The fix is not willpower. It is a script.

The best clinicians in the country are not braver than the new grad sitting across from a demanding patient. They are just better rehearsed. Their words arrive on time because those words were written, practiced, and stress-tested long before the exam room door closed.

“I watched new PMHNPs over and over again write a stimulant or a benzodiazepine they knew was wrong because they did not have language ready. The words do not appear when your heart rate is at 110. You have to rehearse them at rest.” — Lindsay Hill, DNP, PMHNP-BC

Infographic: five-step PMHNP confidence script for declining controlled substance requests
The five-step refusal framework at a glance.

The Pressure Is Real — And It Is Not Your Fault

Patients seeking controlled substances are not usually villains. Most are exhausted people who believe a pill will fix a life problem. A smaller subset are selling, diverting, or dependent. The encounter feels identical from the outside, which is part of what makes refusals so difficult.

New PMHNPs are often well trained in pharmacology. However, refusal language is missed almost entirely. In fact, SAMHSA resources flag controlled substance prescribing as a top-risk skill area. The gap shows up on day one. An otherwise brilliant clinician can fumble a benzodiazepine refusal because no preceptor ever modeled the conversation at full speed under real pressure.

The environment compounds the problem. Productivity quotas, shortened visit lengths, and online review culture all punish friction. The path of least resistance becomes writing the script. That path costs the clinician a piece of their license and the patient a piece of their recovery.

Empty clinical office setting representing the tension of a controlled substance refusal conversation

Why New PMHNPs Cave on Controlled Substance Refusals

Three forces converge in the exam room. Clinical uncertainty — the PMHNP is not yet sure whether the request is legitimate. Social pressure — the patient is frustrated, articulate, and often in tears. Time pressure — the visit is running long and the next patient is already in the lobby.

Under those conditions the brain defaults to the path of least conflict. That path is almost always “yes.” The prefrontal cortex loses to the limbic system every time conflict spikes, and a poorly rehearsed refusal is conflict.

The first move is to remove clinical uncertainty from the encounter entirely. For example, a patient might arrive asking for alprazolam, Adderall, or Xanax. If the clinician has not completed a full diagnostic workup, a PDMP review, and a treatment-planning discussion, no controlled substance is indicated that day. That is not a judgment. That is a clinical fact.

The Five-Step Framework for Controlled Substance Refusals

Step one: name the ask out loud. “It sounds like you are hoping I will prescribe Xanax today.” Naming neutralizes the request. The patient no longer has to wonder whether you understood.

Step two: validate the experience without validating the request. “Panic attacks are exhausting. I believe you.” Validation lowers the temperature. It does not concede the prescription.

Step three: state the clinical position, not the personal preference. “For panic disorder, the first-line treatment is an SSRI plus short-term skills work. Benzodiazepines are not first-line, and starting one today would make the SSRI work slower and less effective.” Clinical positions cannot be argued with. Personal preferences can.

Step four: offer the real treatment. “Here is what I can do for you today. I can start sertraline, give you a short-term plan for panic surges, and see you back in two weeks.” Always leave the room with a plan. Never leave with a fight.

Step five: document the clinical reasoning, the refusal, and the alternative offered. Documentation protects the clinician and anchors the decision for future visits.

What Most PMHNPs Get Wrong About Controlled Substance Refusals

Most new PMHNPs believe the refusal has to feel harsh. It does not. The most effective refusals sound collaborative, not combative. Warmth is a force multiplier on a firm clinical position.

The second assumption that trips new clinicians is that the refusal has to be long. It does not. A two-sentence clinical position beats a five-minute defense every time. The longer the explanation, the more the patient hears negotiation.

The third assumption is the most dangerous. Many new PMHNPs believe a refusal will destroy the therapeutic alliance. The data — and the clinical experience of seasoned prescribers — say the opposite. Patients declined appropriately, with warmth and a real alternative, report higher trust in their provider after six months. Surprisingly, this trust runs higher than in patients who were given exactly what they asked for.

Confidence, in other words, is magnetic.

Symbolic toolbox with compass anchor and stone representing a PMHNP refusal framework

Handling the Four Most Common Pushback Scripts

“My last doctor gave it to me for years.” The response is simple. “I hear that. I am not your last doctor, and I have to prescribe based on what I can defend clinically today. Here is the plan I can support.”

“Nothing else works for me.” Respond to the feeling, not the claim. “That sounds exhausting. Before we rule everything else out, let us actually try the first-line treatments with a real plan and real follow-up. If those fail, we revisit.”

“You are not listening to me.” The temptation is to over-explain. The correct move is to slow down. “I am listening. What I cannot do is prescribe something that I believe will hurt you long-term. What I can do is stay in this with you.”

“I will just find another provider.” Let them. Say it with kindness. “I understand. I would rather you find a prescriber who agrees with a plan. Otherwise, you would take a medication from me that I cannot stand behind.” Patients almost never leave after this sentence. It signals the clinician is not desperate for the visit.

Documentation Pearls for Controlled Substance Refusals

Every refusal should be documented in four lines. The request made. The clinical reasoning. The alternative offered. The patient’s response and the safety plan. If the chart does not say it, it did not happen.

Imagine a future clinician, a board, or a DEA investigator reading the note. In that case, the refusal should make obvious clinical sense within thirty seconds. The note is a standalone defense of a single decision.

“The chart is your receipt. You are not documenting to protect yourself from the patient. You are documenting to make the next clinical decision easier for the next clinician — or for you, in six months, when the same patient returns.” — Lindsay Hill, DNP, PMHNP-BC

Warm desk scene with a chart binder representing careful clinical documentation after a refusal

Frequently Asked Questions

Can a PMHNP refuse to prescribe a controlled substance a previous provider wrote?

Yes, and in many cases they should. A new prescriber has no obligation to continue a prior regimen that does not meet current clinical standards. The refusal must be documented with reasoning and a safe alternative plan, including a taper if discontinuation is warranted.

What if the patient becomes verbally aggressive after a refusal?

Slow the pace, lower the voice, and anchor the refusal in the clinical position rather than debate personal values. If safety becomes a concern, end the visit, document the behavior, and notify the practice owner or supervising clinician. Aggression is a clinical data point, not a reason to cave.

How do I handle a controlled substance request in telehealth?

The same framework still applies. However, you must pay additional attention to the current DEA Diversion Control Division rules on telehealth prescribing and at least one in-person evaluation where required. A refusal script delivered on camera lands exactly like one delivered in the exam room when the clinician has rehearsed it.

Will refusing controlled substances hurt my online reviews?

Occasionally, yes — but far less than most new PMHNPs fear. A pattern of declining inappropriate requests with warmth typically generates more five-star reviews than any clinical skill, because patients remember being heard. The one-star reviews fade fast.

Is it ever appropriate to prescribe a benzodiazepine short-term as a new PMHNP?

Yes, within narrow clinical windows and with clear exit criteria. The confidence script is not “never prescribe.” It is “never prescribe under pressure, without workup, or without a documented plan.” The framework protects good clinical decisions, including the ones that end in a prescription.

The Bottom Line

Declining a controlled substance is not a personality trait. It is a skill. New PMHNPs who rehearse the script, name the ask, validate the patient, state the clinical position, offer a real alternative, and document it cleanly stop losing sleep over these encounters within sixty days of practice.

The one concrete next step: write the five steps on an index card. Read it before any visit in which a controlled substance might come up. Within a month the script becomes automatic. Within three months the pressure stops registering as pressure at all.

Rehearse the Script Before You Need It

The Psych NP Fellowship is a 12-month clinical mentorship program where new and early-career PMHNPs practice these exact encounters in real time with experienced preceptors.

Join the Psych NP Fellowship

This content is for educational purposes and does not replace individualized clinical judgment or supervision.

About the Author

Lindsay Hill, DNP, PMHNP-BC is the founder of the Psych NP Fellowship, a 12-month clinical mentorship program for new and early-career psychiatric nurse practitioners. She is a published contributor to Psychiatric Times, past President of the Arizona APNA Chapter, and co-founder of the Psych NP Network.

About Psych NP Fellowship Team

The Psych NP Fellowship Team provides evidence-based clinical content, prescribing insights, and career guidance for new and early-career psychiatric nurse practitioners. Led by Lindsay Hill, DNP, PMHNP-BC, the team is dedicated to bridging the gap between PMHNP education and confident clinical practice.

Related Posts

Ready to Practice with Calm Confidence?

Book a free discovery call and learn how the Psych NP Fellowship can support your growth.

View All Programs

or Compare All Programs →